Treatment with a Luteinizing Hormone–Releasing Hormone Agonist in Adolescents with Short Stature

Abstract

Treatment with an LHRH agonist for 3.5 years increases adult height by 0.6 SD in adolescents with very short stature but substantially decreases bone mineral density. Such treatment cannot be routinely recommended to augment height in adolescents with normally timed puberty.